Skip to main content

Table 1 Baseline characteristics between CRRT Unreceived /Received Group

From: The association between continuous renal replacement therapy as treatment for sepsis-associated acute kidney injury and trend of lactate trajectory as risk factor of 28-day mortality in intensive care units

Characteristics

CRRT Unreceived

CRRT Received

p value

N

560

157

 

Age

71.0(61.0,81.0)

67.0(58.0, 77.0)

0.001*

Sex n,(%)

  

0.459

 Male

347(62.0)

103(65.6)

 

 Female

213(38.0)

54(34.4)

 

Ethnicity n,(%)

  

0.013*

  White

408 (72.9)

109 (69.4)

 

  Black

85 (15.2)

16 (10.2)

 

  Others

67 (12.0)

32 (20.4)

 

Vital signs

 Mean blood pressure (mmHg)

70.3(65.1,75.6)

68.4(64.1,74.6)

0.057

 Heart rate (min-1)

84.0(73.9,98.2)

86.9(76.8,97.3)

0.271

 Respiratory rate (min-1)

19.7(17.4,22.9)

19.9(17.4,22.8)

0.633

 Oxygen saturation (%)

97.5(96.2,98.9)

97.2(96.0,98.7)

0.119

 Skin temperature (℃)

36.7 (36.2, 37.2)

36.7 (36.2, 37.3)

0.906

Partial pressure of carbon dioxide (mmHg)

39.0(33.0,48.0)

42.0(36.0,48.0)

0.091

Laboratory result

 White Blood Cell (k/uL)

11.80 (7.40, 17.12)

11.70 (7.40, 16.80)

0.850

 Neutrophil/lymphocyte ratio

11.86 (5.90, 21.80)

11.11 (6.80, 21.50)

0.563

 Hemoglobin (g/dL)

10.60 (9.40, 12.10)

10.70 (9.30, 11.90)

0.731

Red blood Cell Distribution Width (%)

16.25 (14.80, 18.20)

16.80 (15.50, 18.40)

0.023*

 Hematocrit (%)

32.60 (28.90, 37.00)

32.60 (28.50, 37.40)

0.999

 Platelet (K/uL)

194.00 (126.25, 272.25)

196.00 (120.00, 271.00)

0.972

 Sodium (mEq/L)

138.00 (134.00, 141.00)

137.00 (133.00, 140.00)

0.017*

 Potassium (mEq/L)

4.50 (4.00, 5.20)

4.60 (4.00, 5.30)

0.320

 Magnesium (mg/dL)

2.00 (1.70, 2.30)

2.00 (1.80, 2.40)

0.034*

 Bicarbonate(mEq/L)

22.0(19.0,26.3)

22.0(18.0,26.0)

0.526

 Phosphate(mg/dL)

3.90 (3.00, 5.00)

4.60 (3.50, 6.20)

 < 0.001*

 Albumin(mg/dL)

2.9(2.5,3.3)

2.8(2.4,3.3)

0.629

 Glucose(mg/dL)

128.00 (102.00, 179.25)

126.00 (98.00, 175.00)

0.789

 Creatinine(K/uL)

2.70 (1.87, 4.20)

3.70 (2.70, 5.20)

 < 0.001*

 PH

7.4(7.3,7.4)

7.3(7.3, 7.4)

0.061

 Urine output (mL)

804.0 (258.5, 1459.4)

195.0(39.0, 602.0)

 < 0.001*

Comorbidities, n (%)

 Congestive heart failure

310 (55.4)

91 (58.0)

0.624

 Hypertension

448 (80.0)

121 (77.1)

0.490

 Liver disease

123 (22.0)

47 (29.9)

0.049*

 Fluid electrolyte

343 (61.3)

96 (61.1)

0.999

Ventilator use n,(%)

255

119

 < 0.001*

 No

305(45.5)

38(75.8)

 

 Yes

255(54.5)

119(24.2)

 

Vasopressor use n,(%)

374

155

 < 0.001*

 No

186(33.2)

2(1.3)

 

 Yes

374(66.8)

155(98.7)

 

SOFA

8.00 (6.00, 10.00)

11.00 (9.00, 12.00)

 < 0.001*

28-Days Mortality n,(%)

  

0.009

 No

307(54.8)

67(42.7)

 

 Yes

253(45.2)

90(57.3)